Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device
SNIP
Sublingual Neonatal Incision Platform (SNIP) Case Series
2 other identifiers
interventional
6
1 country
1
Brief Summary
A study assessing the feasibility of a novel device designed specifically to treat infant tongue-tie.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2026
CompletedFirst Submitted
Initial submission to the registry
May 7, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
CompletedJune 18, 2026
May 1, 2026
3 months
May 7, 2026
June 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinician Device Experience
The physician will be asked to rate following attributes of the use of the tool, in Likert scale of 1-5; Whether the device felt intuitive, whether they felt more confident using this device, whether they would use this device again for a similar release?
Immediately post-op
Secondary Outcomes (1)
Operator-perceived infant discomfort
Immediately post-op
Study Arms (2)
Infant with anterior ankyloglossia requiring intervention
EXPERIMENTALPatient is treated using the novel device
Non-treatment
NO INTERVENTIONPatients identified as not requiring frenectomy
Interventions
Patient treated using the novel device under study
Eligibility Criteria
You may qualify if:
- Anterior ankyloglossia requiring intervention
You may not qualify if:
- Concomitant morphological variation in the oral cavity which could compromise frenectomy Blood dyscrasia Immunocompromise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tunbridge Wells Hospital Pembury
Royal Tunbridge Wells, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aung Soe
Medway NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2026
First Posted
June 18, 2026
Study Start
March 10, 2026
Primary Completion
June 20, 2026
Study Completion
July 1, 2026
Last Updated
June 18, 2026
Record last verified: 2026-05